$EFX

These Analysts Slash Their Forecasts On Equifax After Q2 Results - Equifax (NYSE:EFX)

Equifax reported Q2 adjusted EPS of $2.25, above the $2.20 consensus, and revenue of $1.70B, up 11% and slightly above the $1.696B estimate. It narrowed full-year adjusted EPS guidance to $8.39-$8.69 and tightened revenue outlook to $6.71B-$6.78B. For Q3, it forecast adjusted EPS $2.15-$2.25 and revenue $1.68B-$1.71B. Analysts cut price targets after results.

Original reporting
Published Jul 22, 2026, 4:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 6:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
These Analysts Slash Their Forecasts On Equifax After Q2 Results - Equifax (NYSE:EFX) — source image
Decision brief

The 30-second read

$EFXNeutralMed
01

Why it matters

Traders can reassess expectations using the narrowed FY EPS and revenue ranges and the Q3 EPS range that sits below consensus.

02

Market read

Fresh guidance ranges and same-day analyst target reductions provide actionable inputs for short- to medium-term positioning in EFX.

03

What to watch

Analyst price targets were cut across multiple firms, but the article does not provide the underlying thesis for the cuts beyond the earnings/guidance numbers.

Relevance 8/10Novelty 7/10Timing: post-earnings, same-day guidance and analyst target cuts

Background

The article follows Equifax’s Q2 results and focuses on updated full-year and Q3 guidance ranges.

Company-level read

Ticker impact

$EFXNeutralMedium confidence
Context

Equifax reported adjusted EPS of $2.25 and revenue of $1.70B, then narrowed FY guidance and set Q3 EPS below consensus.

Expected impact

Near-term downside bias versus consensus expectations, with volatility likely around the Q3 outlook.

Evidence & confidence

The article cites FY EPS and revenue midpoint broadly in line with consensus, but Q3 adjusted EPS guidance ($2.15-$2.25) is below the $2.26 estimate and shares fell 2.5%.

Market effects

Credit bureau and consumer data services peers may see read-across on demand and pricing assumptions, but this is company-specific guidance.

Limited regional spillover; guidance is reported in local currency and US-listed equity reaction dominates.

Low global relevance beyond the credit reporting services space.

Counterpoint

FY guidance midpoints are broadly in line with consensus, so the selloff may be overdone if investors focus on full-year stability rather than Q3.

Key entities

  • Equifax

    Reported Q2 adjusted EPS and revenue, narrowed FY guidance, and guided Q3 adjusted EPS below consensus.

  • Needham

    Maintained Buy rating and lowered price target from $265 to $245 after the earnings announcement.

  • Barclays

    Maintained Equal-Weight rating and cut price target from $215 to $200.

  • RBC Capital

    Maintained Outperform rating and lowered price target from $222 to $194.

Related articles

$EFXMedAI 8/10

Equifax Expands LATAM Reach With Círculo de Crédito Deal

Equifax agreed to acquire Mexico credit bureau Círculo de Crédito for $750 million, aiming to expand its Latin America credit, identity, and fraud prevention offerings. Círculo serves 1,700+ customers and has about 80 million validated identities and 2 billion credit tradelines. It generated an estimated $134 million revenue and $62 million adjusted EBITDA (12 months ended June 30, 2026). Closing is expected in Q4 2026, pending approvals.

$EFXMed

Equifax jumps as investors reassess last week’s selloff

Equifax (EFX) shares rose about 6.3% after a prior post-earnings selloff, as investors reassessed the quarter. The company reported Q2 2026 revenue growth of 11%, beat profit expectations, and said it is doubling AI cost savings to $150 million. Equifax also agreed to acquire Mexico’s Círculo de Crédito and returned $366 million via buybacks and dividends.

$EFXMedAI 8/10

Equifax Inc. Q2 2026 Earnings Call Summary

Equifax reported 11% reported revenue growth in Q2 2026, driven by Workforce Solutions and consumer lending, and said EBITDA margin expanded 120 bps excluding FICO. It secured about $300m government contract ACV, announced a $750m acquisition of Círculo de Crédito, raised its AI productivity goal to $150m, and reiterated 2026 guidance and >$1b free cash flow.

$SNDKMed

Stocks Gain as Chipmakers Rebound

Stocks rose as chipmakers and AI-infrastructure shares rebounded. The iShares Semiconductor ETF (SOXX) gained over 3%, while Sandisk (SNDK), Micron (MU), Western Digital (WDC), and others rose. Bitcoin hit a 1-month high, lifting Coinbase (COIN) and Circle (CRCL). Hasbro (HAS) reported Q2 net revenue $1.14B and raised guidance; 3M (MMM) beat EPS and lifted outlook.

$EFXMedAI 8/10

Equifax: Q2 Earnings Snapshot

Equifax Inc. (EFX) reported Q2 net income of $183.9 million, or $1.54 per share. Adjusted EPS was $2.25 versus $2.21 expected by Zacks. Revenue was $1.7 billion versus $1.69 billion expected. For Q3, it forecasts EPS $2.15 to $2.25 and revenue $1.68 to $1.71 billion; full-year EPS $8.39 to $8.69 and revenue $6.71 to $6.78 billion.